ATP Binding Cassette Transporter C8 (ABCC8) Antibody (ATTO488)

Este producto es parte de ABCC - ATP binding cassette subfamily C
Product Graph
637€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
ATP Binding Cassette Transporter C8 (ABCC8) Antibody (ATTO488)
category
Primary Antibodies
provider
Abbexa
reference
abx440450
tested applications
WB, IHC, IF/ICC

Description

ATP Binding Cassette Transporter C8 (ABCC8) Antibody is a Mouse Monoclonal against ATP Binding Cassette Transporter C8 (ABCC8).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
ATP Binding Cassette Transporter C8 (ABCC8)
Host
Mouse
Reactivity
Human, Mouse, Rat, Hamster
Recommended Dilution
WB: 1/1000, IHC: 1/1000, IF/ICC: 1/100. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
ATTO488
Isotype
IgG1
Purification
Purified by Protein G.
Size 1
100 µg
Tested Applications
WB, IHC, IF/ICC
Buffer
PBS, pH 7.4, 50% glycerol, 0.09% sodium azide.
Availability
Shipped within 5-12 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q09429
Gene ID
25559
NCBI Accession
NP_037171.2
Alias
ABC36,HHF1,HI,HRINS,MRP8,PHHI,PNDM3
Background
Antibody anti-ABCC8
Status
RUO
Note
Concentration: 1 mg/ml - 

Descripción

ATP Binding Cassette Subfamily C Member 8 (ABCC8) encodes a sulfonylurea receptor that functions as a regulatory subunit of ATP-sensitive potassium (K-ATP) channels. These channels play a critical role in glucose-induced insulin secretion in pancreatic beta cells by coupling metabolic signals to membrane depolarization. ABCC8 mutations are linked to congenital hyperinsulinism, a condition characterized by unregulated insulin secretion leading to hypoglycemia. The protein is also expressed in cardiac and skeletal muscle tissues, where it regulates cellular energy homeostasis and membrane excitability under metabolic stress. Pharmacologically, ABCC8 is targeted by sulfonylureas and meglitinides, drugs used to treat type 2 diabetes by stimulating insulin secretion. Research highlights its potential role in cardiovascular physiology, particularly in ischemic preconditioning, where it helps protect tissues during periods of low oxygen supply.

Related Products

abx006205

ATP Binding Cassette Transporter C8 (ABCC8) Antibody

ATP Binding Cassette Transporter C8 (ABCC8) Antibody is a Rabbit Polyclonal Antibody against ATP Binding Cassette Transporter C8 (ABCC8).

Ver Producto
abx128425

ATP Binding Cassette Transporter C8 (ABCC8) Antibody

ATP Binding Cassette Transporter C8 (ABCC8) Antibody is a Rabbit Polyclonal against ATP Binding Cassette Transporter C8 (ABCC8).

Ver Producto
abx150510

Human ATP Binding Cassette Transporter C8 (ABCC8) ELISA Kit

Human ATP Binding Cassette Transporter C8 (ABCC8) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Human ATP Binding Cassette Transporter C8 (ABCC8) concentrations in tissue homogenates, cell lysates and other biological fluids. This assay has high sensitivity and excellent specificity for detection of ATP Binding Cassette Transporter C8 (ABCC8)

Ver Producto